Rho Bio

Private

New Haven, ConnecticutHealthcare & Life Scienceshttps://www.rho.bio/

Last Round

Grant

Apr 1, 2026

Company Overview

Rho Bio is a biotechnology company that develops protein-engineered lymphatic activators to treat diseases caused by lymphatic dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryprotein engineeringlymphatic systembiologicstherapeutic developmentdirected evolutioninvestigational new drugINDVEGFR3lymphedema treatmentneuro-ophthalmic diseasepre-clinical biotechdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rho Bio Comps

Public and private peers based on sector, stage, and business model.

Rho Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rho Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2026
Pre Seed	Apr 7, 2025

View all Funding Rounds

Rho Bio Investors

Notable investors and investment history

Rho Bio investors
Investor	Rounds
Connecticut Innovations	Seed
Ono Venture Investment, Inc.	Pre Seed
Mission BioCapital	Seed, Pre Seed

View all Investors

Rho Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Rho Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rho Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut

Employee Range3

Year Founded2024

Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.